Breztri Aerosphere Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial
24 June 2020 -- Full results from the positive Phase III ETHOS trial showed AstraZeneca’s triple-combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) demonstrated a statistically significant reduction in the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 25, 2020 Category: Pharmaceuticals Source Type: clinical trials
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19
Condition: COVID-19 Interventions: Drug: Levamisole Pill + Budesonide+Formoterol inhaler; Drug: Lopinavir/Ritonavir + hydoxychloroquine Sponsor: Fasa University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2020 Category: Research Source Type: clinical trials